Petros Pharmaceuticals, Inc. (PTPI)
OTCMKTS
· Delayed Price · Currency is USD
0.0390
-0.0084 (-17.72%)
At close: May 23, 2025
Petros Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Net Income | -14.42 | -14.32 | -8.16 | -20.04 | -8.99 | -20.59 | Upgrade
|
| Depreciation & Amortization | 2.94 | 2.94 | 3.42 | 5.72 | 6.88 | 6.66 | Upgrade
|
| Other Amortization | - | - | - | - | 0.01 | 0.04 | Upgrade
|
| Asset Writedown & Restructuring Costs | 2.97 | 2.97 | - | 7.46 | - | - | Upgrade
|
| Stock-Based Compensation | 0.26 | 0.47 | 0.42 | 1.2 | 1.31 | - | Upgrade
|
| Provision & Write-off of Bad Debts | -0.01 | -0.01 | 0.03 | -0.17 | 0.15 | 0.2 | Upgrade
|
| Other Operating Activities | 0.86 | 0.82 | -3.95 | -3.87 | -9.46 | 3.98 | Upgrade
|
| Change in Accounts Receivable | 1.82 | 1.82 | -0.14 | 0.52 | 2.55 | -2.75 | Upgrade
|
| Change in Inventory | -0.16 | -0.16 | -0.91 | -0.84 | 0.41 | 0.73 | Upgrade
|
| Change in Accounts Payable | 0.45 | 0.62 | -0.09 | -2.75 | -1.05 | 2.22 | Upgrade
|
| Change in Unearned Revenue | -0.12 | -0.12 | -0.16 | 0.21 | - | - | Upgrade
|
| Change in Other Net Operating Assets | 2.35 | 2.37 | 1.94 | -0.23 | -3.67 | -5.8 | Upgrade
|
| Operating Cash Flow | -3.13 | -2.6 | -7.63 | -12.8 | -11.86 | -15.31 | Upgrade
|
| Capital Expenditures | -0.02 | -0.02 | - | - | - | -0 | Upgrade
|
| Investing Cash Flow | -0.02 | -0.02 | - | - | - | -0 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | - | 15.5 | Upgrade
|
| Total Debt Issued | - | - | - | - | - | 15.5 | Upgrade
|
| Long-Term Debt Repaid | - | -0.77 | -1.46 | -1.62 | -7.19 | -6.72 | Upgrade
|
| Net Debt Issued (Repaid) | -0.77 | -0.77 | -1.46 | -1.62 | -7.19 | 8.78 | Upgrade
|
| Issuance of Common Stock | 8.71 | - | 15 | - | 25.76 | 0.02 | Upgrade
|
| Other Financing Activities | - | - | - | - | - | 21.5 | Upgrade
|
| Financing Cash Flow | 2.83 | -7 | 11.54 | -1.62 | 18.57 | 30.3 | Upgrade
|
| Net Cash Flow | -0.32 | -9.63 | 3.91 | -14.42 | 6.71 | 14.99 | Upgrade
|
| Free Cash Flow | -3.15 | -2.63 | -7.63 | -12.8 | -11.86 | -15.31 | Upgrade
|
| Free Cash Flow Margin | -61.68% | -51.40% | -130.99% | -213.57% | -151.86% | -160.16% | Upgrade
|
| Free Cash Flow Per Share | -5.59 | -8.19 | -87.62 | -154.54 | -272.32 | -716.66 | Upgrade
|
| Cash Interest Paid | 0.23 | 0.23 | 0.54 | 0.6 | 0.42 | 1.19 | Upgrade
|
| Levered Free Cash Flow | 15.38 | 1.3 | -1.39 | -26.93 | -5 | -4.55 | Upgrade
|
| Unlevered Free Cash Flow | 15.73 | 1.65 | -1.05 | -26.56 | -4.78 | -2.69 | Upgrade
|
| Change in Net Working Capital | -18.75 | -4.7 | -1.84 | 23.57 | 1.69 | -1.46 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.